HallE.D. (1995). Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J. Neurol. Sci., 134, Suppl, 79–83.
2.
YoungB., RungeJ.W., WaxmanK.S., HarringtonT., WilbergerJ., MuizelaarJ.P., BoddyA., and KupiecJ.W. (1996). Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA, 276, 538–543.
3.
BayırH., KaganV.E., TyurinaY.Y., TyurinV.A., RuppelR.A., AdelsonP.D., GrahamS.H., JaneskoK., ClarkR.S., and KochanekP.M. (2002). Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr. Res., 51, 571–578.
4.
BayırH., TyurinV.A., TyurinaY.Y., VinerR., RitovV., AmoscatoA., ZhaoQ., ZhangX.J., Janesko-FeldmanK.L., AlexanderH., BasovaL.V., ClarkR.S., KochanekP.M., and KaganV.E. (2007). Selective early cardiolipin oxidation after brain trauma: A lipidomics analysis. Ann. Neurol., 62, 154–169.
5.
KaganV.E., BayırH., BelikovaN.A., KapralovO., TyurinaY.Y., TyurinV.A., JiangJ., StoyanovskyD.A., WipfP., KochanekP.M., GreenbergerJ.S., PittB., ShvedovaA.A., and BorisenkoG. (2009). Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic. Biol. Med., 46, 1439–1453.
6.
SparveroL.J., AmoscatoA.A., DixonC.E., LongJ.B., KochanekP.M., PittB.R., BayırH., and KaganV.E. (2012). Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations. Chem. Phys. Lipids, 165, 545–562.
7.
JiJ., KlineA.E., AmoscatoA., Samhan-AriasA., SparveroL.J., TyurinV.A., TyurinaY.Y., FinkB., ManoleM.D., PuccioA.M., OkonkwoD.O., ChengJ.P., AlexanderH., ClarkR.S., KochanekP.M., WipfP., KaganV.E., and BayırH. (2012). Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nat. Neurosci., 15, 1407–1413.
8.
AnthonymuthuT.S., KennyE.M., AmoscatoA.A., LewisJ., KochanekP.M., KaganV.E., and BayırH. (2017). Global assessment of oxidized free fatty acids in brain reveals an enzymatic predominance to oxidative signaling after trauma. Biochim. Biophys. Acta, 17, 30102–30103.
9.
Van Den BrenkH.A., and JamiesonD. (1962). Pulmonary damage due to high pressure oxygen breathing in rats. I. Lung weight, histological and radiological studies. Aust. J. Exp. Biol. Med. Sci., 40, 37–49.
10.
WinterP.M., and SmithG. (1972). The toxicity of oxygen. Anesthesiology, 37, 210–241.
11.
GowdeyC.W., PatelY.J., and StavrakyG.W. (1965). Brain lesions and hyperbaric oxygen convulsions. Int. J. Neuropsychiatry, 1, 318–324.
12.
KilgannonJ.H., JonesA.E., ShapiroN.I., AngelosM.G., MilcarekB., HunterK., ParrilloJ.E., and TrzeciakS.; Emergency Medicine Shock Research Network (EMShockNet) Investigators. (2010). Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA, 303, 2165–2171.
13.
VereczkiV., MartinE., RosenthalR.E., HofP.R., HoffmanG.E., and FiskumG. (2006). Normoxic resuscitation after cardiac arrest protects against hippocampal oxidative stress, metabolic dysfunction, and neuronal death. J. Cereb. Blood Flow Metab., 26, 821–835.
14.
RamanS., PrinceN.J., HoskoteA., RayS., and PetersM.J. (2016). Admission PaO2 and mortality in critically ill children: a cohort study and systematic review. Pediatr. Crit. Care Med., 17, e444–e450.
15.
Sznycer-TaubN.R., LoweryR., YuS., OwensS.T., Hirsch-RomanoJ.C., and OwensG.E. (2016). Hyperoxia is associated with poor outcomes in pediatric cardiac patients supported on venoarterial extracorporeal membrane oxygenation. Pediatr. Crit. Care Med., 17, 350–358.
16.
HelmerhorstH.J., Roos-BlomM.J., van WesterlooD.J., and de JongeE. (2015). Association between arterial hyperoxia and outcome in subsets of critical illness: a systematic review, meta-analysis, and meta-regression of cohort studies. Crit. Care Med., 43, 1508–1519.
17.
HawrylukG.W., and ManleyG.T. (2015). Classification of traumatic brain injury: past, present, and future. Handb. Clin. Neurol., 127, 15–21.
18.
KochanekP.M., BramlettH.M., ShearD.A., DixonC.E., MondelloS., DietrichW.D., HayesR.L., WangK.K., PoloyacS.M., EmpeyP.E., PovlishockJ.T., MountneyA., BrowningM., Deng-BryantY., YanH.Q., JacksonT.C., CataniaM., GlushakovaO., RichieriS.P., and TortellaF.C. (2016). Synthesis of findings, current investigations, and future directions: Operation Brain Trauma Therapy. J. Neurotrauma, 33, 606–614.
19.
KochanekP.M., and BellM.J. (2015). Tackling the challenges of clinical trials for severe traumatic brain injury in children: screening, phenotyping, and adapting. Crit. Care Med., 43, 1544–1546.
20.
BrennerM., SteinD., HuP., KuferaJ., WoofordM., and ScaleaT. (2012). Association between early hyperoxia and worse outcomes after traumatic brain injury. Arch. Surg., 147, 1042–1046.
21.
RinconF., KangJ., VibbertM., UrtechoJ., AtharM.K., and JalloJ. (2014). Significance of arterial hyperoxia and relationship with case fatality in traumatic brain injury: a multicentre cohort study. J. Neurol. Neurosurg. Psychiatry, 85, 799–805.
22.
RockswoldS.B., RockswoldG.L., ZaunD.A., and LiuJ. (2013). A prospective, randomized Phase II clinical trial to evaluate the effect of combined hyperbaric and normobaric hyperoxia on cerebral metabolism, intracranial pressure, oxygen toxicity, and clinical outcome in severe traumatic brain injury. J. Neurosurg., 118, 1317–1328.
23.
PuccioA.M., HoffmanL.A., BayırH., ZulloT.G., FischerM., DarbyJ., AlexanderS., DixonC.E., OkonkwoD.O., and KochanekP.M. (2009). Effect of short periods of normobaric hyperoxia on local brain tissue oxygenation and cerebrospinal fluid oxidative stress markers in severe traumatic brain injury. J. Neurotrauma, 26, 1241–1249.
24.
Vidal-JorgeM., Sánchez-GuerreroA., Mur-BonetG., CastroL., RădoiA., RiveiroM, Fernández-PradoN., BaenaJ., PocaM.A., and SahuquilloJ. (2017). Does normobaric hyperoxia cause oxidative stress in the injured brain? A microdialysis study using 8-iso-PGF2a as a biomarker. J. Neurotrauma., 34, 2731–2742.
25.
BayırH., MarionD.W., PuccioA.M, WisniewskiS.R., JaneskoK.L., ClarkR.S., and KochanekP.M. (2004). Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J. Neurotrauma, 21, 1–8.
26.
BlasioleB., BayırH., VagniV.A., Janesko-FeldmanK., CheikhiA., WisniewskiS.R., LongJ., AtkinsJ., KaganV., and KochanekP.M. (2013). Effect of hyperoxia on resuscitation of experimental combined traumatic brain injury and hemorrhagic shock in mice. Anesthesiology, 118, 649–663.
27.
MaasA.I., MurrayG.D., RoozenbeekB., LingsmaH.F., ButcherI., McHughG.S., WeirJ., LuJ., and SteyerbergE.W.; International Mission on Prognosis Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) Study Group. (2013). Advancing care for traumatic brain injury: findings from the IMPACT studies and perspectives on future research. Lancet Neurol. 12, 1200–1210.
28.
LarsenG.Y., SchoberM., FabioA., WisniewskiS.R., GrantM.J., ShafiN., BennettT.D., HirtzD., and BellM.J. (2016). Structure, process, and culture differences of pediatric trauma centers participating in an international comparative effectiveness study of children with severe traumatic brain injury. Neurocrit. Care, 24, 353–360.
29.
KurzJ.E., PoloyacS.M., AbendN.S., FabioA., BellM.J., and WainwrightM.S.; Investigators for the Approaches and Decisions in Acute Pediatric TBI Trial. (2016). Variation in anticonvulsant selection and electroencephalographic monitoring following severe traumatic brain injury in children—understanding resource availability in sites participating in a comparative effectiveness study. Pediatr. Crit. Care Med., 17, 649–657.
30.
van't ErveT.J., LihF.B., KadiiskaM.B., DeterdingL.J., ElingT.E., and MasonR.P. (2015). Reinterpreting the best biomarker of oxidative stress: the 8-iso-PGF(2α)/PGF(2α) ratio distinguishes chemical from enzymatic lipid peroxidation. Free Radic. Biol. Med., 83, 245–251.
31.
van't ErveT.J., LihF.B., JelsemaC., DeterdingL.J., ElingT.E., MasonR.P., and KadiiskaM.B. (2016). Reinterpreting the best biomarker of oxidative stress: The 8-iso-prostaglandin F2α/prostaglandin F2α ratio shows complex origins of lipid peroxidation biomarkers in animal models. Free Radic. Biol. Med., 95, 65–73.
32.
HlatkyR., ValadkaA.B., GopinathS.P., and RobertsonC.S. (2008). Brain tissue oxygen tension response to induced hyperoxia reduced in hypoperfused brain. J. Neurosurg., 108, 53–58.
33.
VeenithT.V., CarterE.L., GeeraertsT., GrossacJ., NewcombeV.F., OuttrimJ., GeeG.S., LupsonV., SmithR., AigbirhioF.I., FryerT.D., HongY.T., MenonD.K., and ColesJ.P. (2016). Pathophysiologic mechanisms of cerebral ischemia and diffusion hypoxia in traumatic brain injury. JAMA Neurol. 73, 542–550.
34.
MarshallL.F., MaasA.I., MarshallS.B., BricoloA., FearnsideM., IannottiF., KlauberM.R., LagarrigueJ., LobatoR., PerssonL., PickardJ.D., PiekJ., ServadeiF., WellisG.N., MorrisG.F., MeansE.D., and MuschB. (1998). A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J. Neurosurg., 89, 519–525.
35.
ShethK.N., ElmJ.J., MolyneauxB.J., HinsonH., BeslowL.A., SzeG.K., OstwaldtA.C., Del ZoppoG.J., SimardJ.M., JacobsonS., and KimberlyW.T. (2016). Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 15, 1160–1169.
36.
LairdM.D., ShieldsJ.S., Sukumari-RameshS., KimblerD.E., FesslerR.D., ShakirB., YoussefP., YanasakN., VenderJ.R., and DhandapaniK.M. (2014). High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia, 62, 26–38.
37.
JhaR.M., PuccioA., OkonkwoD., ZusmanB.E., ParkS.Y., WallischJ., EmpeyP.E., ShutterL.A., ClarkR.S., KochanekP.M., and ConleyY.P. (2017). ABCC8 single nucleotide polymorphisms are associated with cerebral edema in severe TBI. Neurocrit. Care, 26, 213–224.
38.
BrockmanE.C., BayırH., BlasioleB., SheinS.L., FinkE.L., DixonC.E., ClarkR.S., VagniV.A., MaL., HsiaC.J., TishermanS.A., and KochanekP.M. (2013). Polynitroxylated-pegylated hemoglobin attenuates fluid requirements and brain edema in combined traumatic brain injury plus hemorrhagic shock in mice. J. Cereb. Blood Flow Metab., 33, 1457–1464.
39.
BrockmanE.C., JacksonT.C., DixonC.E., BayırH., ClarkR.S., VagniV., FeldmanK., ByrdC., MaL., HsiaC., and KochanekP.M. (2017). Polynitroxylated pegylated hemoglobin—a novel, small volume therapeutic for traumatic brain injury resuscitation: comparison to whole blood and dose response evaluation. J. Neurotrauma, 34, 86–96.
40.
JhaR.M., PuccioA., ChouY., ChangC.C., WallischJ., MolyneauxB.J., ZusmanB.E., ShutterL.A., PoloyacS.M., Janesko-FeldmanK.L., OkonkwoD.O., and KochanekP.M. (2017). Sulfonylurea receptor-1: a novel biomarker for cerebral edema in severe traumatic brain injury. Crit. Care Med., 45, e255–e264.
